Please use this identifier to cite or link to this item:
http://sgc.anlis.gob.ar/handle/123456789/1615| DC Field | Value | Language |
|---|---|---|
| dc.date.accessioned | 2020-06-21T16:04:30Z | - |
| dc.date.available | 2020-06-21T16:04:30Z | - |
| dc.date.issued | 2020-06-18 | - |
| dc.identifier.uri | https://www.diario26.com/285894--coronavirus-cinco-claves-del-suero-hiperinmune-de-caballo-que-sera-probado-en-humanos | - |
| dc.identifier.uri | http://sgc.anlis.gob.ar/handle/123456789/1615 | - |
| dc.description.abstract | Podría ser una válida alternativa de inmunización pasiva más efectiva para minimizar los efectos del COVID-19 a corto y mediano plazo. Espera aprobación de ANMAT. | en_US |
| dc.publisher | Diario 26 | en_US |
| dc.subject | COVID19 | en_US |
| dc.subject | Medios de Comunicación | en_US |
| dc.subject | Suero Terapéutico COVID19 | en_US |
| dc.title | Coronavirus: cinco claves del suero hiperinmune de caballo que será probado en humanos | en_US |
| dc.type | Medios | en_US |
| item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
| item.cerifentitytype | Publications | - |
| item.grantfulltext | open | - |
| item.openairetype | Medios | - |
| item.fulltext | With Fulltext | - |
| Appears in Collections: | ANLIS frente a la epidemia COVID-19 | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Coronavirus cinco claves del suero hiperinmune de caballo que será probado en humanos.pdf | 422.39 kB | Adobe PDF |  View/Open |
Page view(s)
88
checked on Apr 26, 2024
Download(s)
11
checked on Apr 26, 2024
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.